EPIRUS Biopharmaceuticals, Inc. 4
4 · EPIRUS Biopharmaceuticals, Inc. · Filed Nov 3, 2015
Insider Transaction Report
Form 4
Shea Thomas A.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2015-11-03$1.30/sh+28,926$37,604→ 28,926 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2015-11-03−28,926→ 20,662 totalExercise: $1.30Exp: 2023-07-08→ Common Stock (28,926 underlying)
Footnotes (2)
- [F1]The option became exercisable with respect to 25% of the shares on June 3, 2014 and with respect to the remaining shares in substantially equal monthly installments over the remaining 3 years.
- [F2]Expiration date corrected from previously reported date of 07/07/2023 to 07/08/2023.